Elan Maxipime Shortage Due To Manufacturing Suspension
Maxipime manufacturer Bristol-Myers Squibb says it temporarily stopped manufacturing cefepime in January due to documentation issues related to bulk manufacturing. FDA accepts Bristol request to release additional product under an amended filing April 12, Bristol says.